Please login to the form below

Not currently logged in
Email:
Password:

Sonia Ruiz Moran appointed president of EMVO

She joins the verification organisation from the General Pharmaceutical Council of Spain

European Medicines Verification Organisation (EMVO) Sonia Ruiz MoranThe European Medicines Verification Organisation (EMVO) has appointed Sonia Ruiz Moran as its new president, replacing John Chave, former secretary general of Pharmaceutical Group of the European Union (PGEU).

She comes to the EMVO with a wealth of pharma experience, having led European Public Affairs at the General Pharmaceutical Council of Spain, since 2008.

This saw her head up the Council's Brussel's office, providing strategic advice in EU regulatory affairs, together with advocacy on initiatives with an impact on health issues.

Prior to joining the General Pharmaceutical Council of Spain, Ruiz Moran worked at Prisa, a leading education and entertainment-focused media holding company in Spanish-speaking countries.

She said: “The planning and design of a pan-European medicine verification system has been very complex. I believe that our mission now is about helping stakeholders in Member States to implement national verification systems that function at an equal level of efficacy, are interoperable and cost effective, in order to prevent falsified medicines from reaching patients, in accordance with EU legislation.”

Set up in February by a group of European trade associations that includes EFPIA and its counterparts in generics, biosimilars and wholesalers, the EMVO is based in Luxembourg.

21st July 2015

From: Regulatory

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
SEVEN STONES

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics